Literature DB >> 9128954

Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation.

S P Reddy1, J E Marks.   

Abstract

PURPOSE: To compare the outcome for patients with squamous cell carcinoma of cervical lymph nodes metastatic from an unknown primary site who were irradiated to both sides of the neck and potential mucosal sites with opposed photon beams, and for those irradiated to the ipsilateral side of the neck alone with an electron beam. METHODS AND MATERIALS: Fifty-two patients with squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site were irradiated by two different methods. Thirty-six were irradiated with a bilateral technique (BT), i.e., to both sides of the neck, including the naso-oro-hypopharyngeal mucosa, and 16 were irradiated with an electron beam (EB) to the ipsilateral side of the neck alone. Twenty patients of the BT group and 11 of the EB group had cervical lymph node dissections, and the remaining 21 patients had lymph node biopsies, prior to radiotherapy.
RESULTS: Tumor control in the ipsilateral side of the neck did not differ for either radiation technique, but was significantly higher after lymph node dissection than after biopsy (90 vs. 48%; p = 0.0004). Control of subclinical metastases in the contralateral cervical lymph nodes was higher for patients irradiated with BT than for patients irradiated with EB (86 vs. 56%; p = 0.03). The occult primary was later discovered in 8% of the patients in the BT group and 44% of the EB group (p = 0.0005). The disease-free survival rate at 5 years for patients who had lymph node dissection prior to irradiation was 61%, and was 37% for those who had biopsy (p = 0.05). Only 20% of patients who subsequently developed an occult primary were salvaged and survived for 5 years after salvage treatment.
CONCLUSION: Bilateral neck and mucosal irradiation is superior to ipsilateral neck irradiation in preventing contralateral cervical lymph node metastases and the subsequent appearance of an occult primary cancer. Both techniques combined with cervical lymph node dissection were equally effective in controlling the ipsilateral neck disease.

Entities:  

Mesh:

Year:  1997        PMID: 9128954     DOI: 10.1016/s0360-3016(97)00025-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  26 in total

1.  Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.

Authors:  Candan Demiroz; Jeffrey M Vainshtein; Georgios V Koukourakis; Orit Gutfeld; Mark E Prince; Carol R Bradford; Gregory T Wolf; Scott McLean; Francis P Worden; Douglas B Chepeha; Matthew J Schipper; Jonathan B McHugh
Journal:  Head Neck       Date:  2013-11-18       Impact factor: 3.147

2.  Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.

Authors:  Huaising C Ko; Shuai Chen; Aaron M Wieland; Menggang Yu; Andrew M Baschnagel; Gregory K Hartig; Paul M Harari; Matthew E Witek
Journal:  Head Neck       Date:  2017-07-24       Impact factor: 3.147

3.  Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary.

Authors:  S Janssen; C Glanzmann; G Huber; G Studer
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

4.  Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.

Authors:  John Cuaron; Shyam Rao; Suzanne Wolden; Michael Zelefsky; Karen Schupak; Borys Mychalczak; Nancy Lee
Journal:  Head Neck       Date:  2015-07-06       Impact factor: 3.147

Review 5.  Diagnosis and management of neck metastases from an unknown primary.

Authors:  L Calabrese; B A Jereczek-Fossa; J Jassem; A Rocca; R Bruschini; R Orecchia; F Chiesa
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

6.  Induction chemotherapy followed by radiotherapy in patients with cervical lymph node metastases from unknown primary carcinoma.

Authors:  Young Mi Seol; Young Jin Choi; Byung Joo Lee; Soo Geun Wang
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-09-17

7.  Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.

Authors:  Marianna Trignani; Angela Argenone; Saide Di Biase; Daniela Musio; Anna Merlotti; Stefano Ursino; Ester Orlandi; Domenico Genovesi; Almalina Bacigalupo
Journal:  Radiol Med       Date:  2019-03-09       Impact factor: 3.469

8.  Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.

Authors:  K Fakhrian; R Thamm; S Knapp; M Molls; S Pigorsch; B Haller; H Geinitz
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

9.  Metastatic squamous cell carcinoma neck with occult primary: A retrospective analysis.

Authors:  Pragya Shukla; Deepak Gupta; Shyam Singh Bisht; Mohan Chand Pant; Madan Lal Bhatt; Kirti Srivastava; Mahendra Pal Singh Negi
Journal:  Indian J Med Paediatr Oncol       Date:  2009-10

10.  Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).

Authors:  Jens Müller von der Grün; Dimitra Bon; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2018-05-14       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.